Stockscreener 앱 받기
1.78
0.85%
0.01
시간 외 거래:
1.79
0.01
+0.56%
전일 마감가:
$1.77
열려 있는:
$1.78
하루 거래량:
267.10K
Relative Volume:
1.45
시가총액:
$78.57M
수익:
-
순이익/손실:
$-28.54M
주가수익비율:
-2.7813
EPS:
-0.64
순현금흐름:
$-22.72M
1주 성능:
+0.85%
1개월 성능:
+14.42%
6개월 성능:
-67.49%
1년 성능:
-70.64%
1일 변동 폭
$1.75
$1.85
1주일 범위
$1.75
$1.905
52주 변동 폭
$1.40
$7.88
Essa Pharma Inc Stock (EPIX) Company Profile
명칭
Essa Pharma Inc
전화
(778) 331-0962
주소
SUITE 720, VANCOUVER, BC
EPIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EPIX
Essa Pharma Inc
|
1.78 | 78.57M | 0 | -28.54M | -22.72M | -0.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
496.44 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
610.87 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
620.49 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
254.85 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
249.83 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-04 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-11-04 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-11-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-06-26 | 재개 | Oppenheimer | Outperform |
| 2021-03-04 | 개시 | Piper Sandler | Overweight |
| 2021-01-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-11-02 | 개시 | Jefferies | Buy |
| 2019-10-25 | 개시 | Oppenheimer | Outperform |
모두보기
Essa Pharma Inc 주식(EPIX)의 최신 뉴스
Press Release Distribution & PR Platform - ACCESS Newswire
Investors who hold shares of ESSA Pharma Inc. (NASDAQ: EPIX) Long - openPR.com
Alis Biosciences Launches To Free Cash From Stalled-Out Biotechs - insights.citeline.com
Finance Watch: Investors Push ESSA Pharma, Elevation Oncology To Wind Down - insights.citeline.com
ESSA Pharma Inc. (NASDAQ:EPIX): Are Analysts Optimistic? - simplywall.st
We're Not Very Worried About ESSA Pharma's (NASDAQ:EPIX) Cash Burn Rate - Yahoo Finance
The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire
ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pha - GuruFocus
ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - Markets Insider
EPIX Deadline Today: Rosen Law Firm Urges ESSA Pharma Inc. (NASDAQ: EPIX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
ESSA Pharma Inc. Investors: Please contact the Portnoy Law - GlobeNewswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - Business Wire
The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pen - GuruFocus
ESSA Pharma Inc. Securities Fraud Class Action Lawsuit - GlobeNewswire
EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Shareholders that lost money on ESSA Pharma Inc.(EPIX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
EPIX IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, - GlobeNewswire
EPIX IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class ActionEPIX - TradingView
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - GlobeNewswire Inc.
ESSA Pharma Inc. Faces Securities Fraud Class Action Over Alleged Investor Misleading Statements - Apna Kal
Investors in ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX - ACCESS Newswire
Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - Longview News-Journal
ESSA Pharma Inc. (NASDAQ: EPIX) Investor Alert: Deadline in Lawsuit on March 25, 2025 - openPR
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ESSA, Cardlytics, Novo Nordisk, and Crocs and Encourages Investors to Contact the Firm - TradingView
EPIX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 25 Deadline in Securities Class ActionEPIX - TradingView
The Gross Law Firm Reminds ESSA Pharma Inc. Investors of - GlobeNewswire
The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – EPIX - TradingView
EPIX Lawsuit Alert! Class Action Lawsuit Against ESSA Pharma, Inc. - TipRanks
EPIX Investors Have Final Opportunity Approaching to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
EPIX Deadline: EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit - PR Newswire
Levi & Korsinsky Notifies Shareholders of ESSA Pharma - GlobeNewswire
ESSA Pharma Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX - ACCESS Newswire
EPIX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - StreetInsider.com
2025-03-17 | INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma | NDAQ:EPIX | Press Release - Stockhouse Publishing
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ESSA Pharma Inc. and Certain OfficersEPIX - PR Newswire
ESSA Pharma Inc. Class Action: The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire
2025-03-16 | ESSA Pharma Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing
EPIX Stockholders Have Opportunity to Lead ESSA Pharma Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - Markets Insider
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
Levi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineEPIX - Stockhouse Publishing
EPIX FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages - GlobeNewswire
EPIX FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - GlobeNewswire Inc.
EPIX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ESSA Pharma Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
2025-03-14 | Investors who lost money on ESSA Pharma Inc.(EPIX) should contact Levi & Korsinsky about pending Class ActionEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
Essa Pharma Inc (EPIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.63%
자본화:
|
볼륨(24시간):